Abstract
Five cases are reported ofFusarium infection in patients with aplasia following chemotherapy of leukemia. The clinical signs, diagnosis and course of the infection during treatment are outlined and discussed in conjunction with the characteristics of other cases already reported in the literature. Sixty-three cases ofFusarium infection have been reported in immunocompromised patients, 44 cases since 1985. These included patients with hematological malignancies (58 cases), especially acute leukemia (43 cases). The main sites of infection were the skin (46 cases), blood (28 cases) and lungs (13 cases). The infection was mostly diagnosed by means of skin biopsy but also by means of positive blood cultures. Forty-three strains were identified, 19 of which wereFusarium solani. Amphotericin B treatment was given in 55 cases, often combined with other antifungal agents, leukocyte transfusions or granulocyte-macrophage-colony stimulating factor. The outcome was fatal in 36 of the 63 cases reported, often due to resistance of the strain to antifungal agents, particularly amphotericin B (20 of 33 strains tested). The most important risk factor seems to be profound and prolonged aplasia. Deep mycoses due toFusarium species thus pose an important problem and are occurring in increasing numbers in immunocompromised patients. Treatment of these infections is difficult and the prognosis is poor.
Similar content being viewed by others
References
Cho CT, Vats TS, Lowman JT, Bransberg JW, Tosh FE Fusarium solani infection during treatment for acute leukemia. Journal of Pediatrics 1973, 83: 1028–1031.
Datry A, Leblond V, Feger C, Gabarre J, Gueho E, Lecso G, Danis M, Binet JL, Gentilini M A propos de trois cas de mycose aFusarium sp. Bulletin de la Société Française de Mycologie Médicale 1988, XVII: 137–142.
Agamanolis DP, Kalwinsky DK, Krill Jr CE, Dasu S, Halasa B, Galloway PG Fusarium meningoencephalitis in a child with acute leukemia. Neuropediatrics 1991, 22: 110–112.
Mayer CF Endemic panmyelotoxicosis in the Russian grain belt. I: The clinical aspects of alimentary toxic aleukia: a comprehensive review. Military Surgeon 1953, 113: 173–189.
Gutmann L, Chou SM, Pore RS Fusariosis, myasthenic syndrome and aplastic anemia. Neurology 1975, 25: 922–926.
Young NA, Kwong-Chung KJ, Kubota TT, Jennings AE, Fischer RI Disseminated infection byFusarium moniliforme during treatment for malignant lymphoma. Journal of Clinical Microbiology 1978, 7: 589–594.
Mutton KJ, Lucas TJ, Harkness JL DisseminatedFusarium infection. Medical Journal of Australia 1980, 2: 624–625.
Perez-Villaroya JC, Fernandez-Guerrero ML, Moran V, Ponte MC, Soriano F, Barat A, de Villalobos E Fusarium oxysporum infection. Journal of Infection 1982, 5: 307–310.
Steinberg GK, Britt RH, Enzmann DR, Finlay JL, Arvin AM Fusarium brain abscess. Journal of Neurosurgery 1983, 56: 598–601.
Blazar BR, Hurd D, Snover DC, Alexander JW, McGlave FB InvasiveFusarium infections in bone marrow transplant recipients. American Journal of Medicine 1984, 77: 645–651.
Gamis AS, Gudnason T, Giebink GS, Ramsay NKC Disseminated infection withFusarium in recipients of bone marrow transplants. Reviews of Infectious Diseases 1991, 13: 1077–1088.
Kiehn TE, Nelson PE, Bernard EM, Edwards FF, Koziner B, Armstrong D Catheter-associated fungemia caused byFusarium chlamydosporum in a patient with lymphocytic lymphoma. Journal of Clinical Microbiology 1985, 21: 501–504.
Poirot JL, Laporte JP, Gueho E, Tessier F, Verny A, Marteau M, Roux P, Duhamel G A propos d'un cas de mycose profonde áFusarium verticillioides. Médecine et Maladies Infectieuses 1985, 10: 529–532.
Poirot JL, Laporte JP, Gueho E, Verny A, Gorin NC, Marteau M, Roux P Mycose profonde áFusarium. Presse Médicale 1985, 14: 2300.
Anaissie EJ, Katarjian H, Jones P, Barlogie B, Luna M, Lopez-Berenstein G, Bodey GP Fusarium: a newly recognized fungal pathogen in immunosuppressed patients. Cancer 1986, 57: 2141–2145.
Anaissie EJ, Katarjian H, Jones P Fungal infection caused byFusarium in cancer patients. American Journal of Clinical Oncology 1987, 10: 86–88.
Chaulk CP, Smith PW, Feagler JR, Verdirame J, Commers JR Fungemia due toFusarium solani in an immunocompromised child. Pediatric Infectious Diseases 1986, 5: 363–366.
June CH, Beatty PG, Shulman H, Rinaldi MG DisseminatedFusarium moniliforme infection after allogeneic marrow transplantation. Southern Medical Journal 1986, 79: 513–515.
Matsuda T, Matsumoto T Disseminated hyalohyphomycosis in a leukemic patient. Archives of Dermatology 1986, 122: 1171–1175.
Okuda C, Ito M, Sato Y, Oka K, Hotchi M Disseminated cutaneousFusarium infection with vascular invasion in a leukemic patient. Journal of Medical and Veterinary Mycology 1987, 25: 177–186.
Stish-Veglia K, Marks VJ Fusarium as a pathogen. A case report ofFusarium sepsis and review of literature. Journal of the American Academy of Dermatology 1987, 16: 260–263.
Anaissie EJ, Katarjian H, Roe J, Hopfer R, Rolson K, Fainstein V, Bodey G The emerging role ofFusarium infections in patients with cancer. Medicine 1988, 67: 77–83.
Merz WG, Karp JE, Hoagland M, Jett-Goheen M, Junkins JM, Hood AF Diagnosis and successful treatment of fusariosis in the compromised host. Journal of Infectious Diseases 1988, 158: 1046–1055.
Mowbray DN, Paller AS, Nelson PE, Kaplan RL DisseminatedFusarium solani infection with cutaneous nodules in a bone marrow transplant recipient. International Journal of Dermatology 1988, 27: 698–701.
Nati R, Dreyfus F, Lanore JJ, Brunet F, Robin P, Bordier C, Dupouy-Camet J Localisations cutanées d'une septicémie àFusarium oxysporum survenant chez un patient en aplasie médullaire. Annales de Dermatologie et de Venéréologie 1988, 115: 337–338.
Richardson SE, Bannantyne RM, Summerbell RC, Milliken J, Gold R, Weitzmen SS Disseminated fusarial infection in the immunocompromised host. Reviews of Infectious Diseases 1988, 10: 1171–1181.
Summerbell RC, Richardson SE, Kane J Fusarium proliferatum as an agent of disseminated infection in an immunosuppressed patient. Journal of Clinical Microbiology 1988, 26: 82–87.
Rippon JW, Larson RA, Rosenthal DM, Clayman J Disseminated cutaneous and peritoneal hyalohyphomycosis caused byFusarium species: three cases and review of the literature. Mycopathologia 1988, 101: 105–111.
Venditti M, Micozzi A, Gentile G, Polonelli L, Morace G, Bianco P, Avvisati G, Papa G, Martino P InvasiveFusarium solani infections in patients with acute leukemia. Reviews of Infectious Diseases 1988, 10: 653–660.
Minor RL, Pfaller MA, Gingrich RD, Burns LJ DisseminatedFusarium infections in patients following bone marrow transplantation. Bone Marrow Transplantation 1989, 4: 653–658.
Barrios NJ, Kirkpatrick D, Murciano A, Stine K, Van Dyke RB, Humbert JR Successful treatment of disseminatedFusarium infection in an immunocompromised child. American Journal of Pediatric Hematology/Oncology 1990, 12: 319–324.
El-Ani AS Disseminated infection caused byFusarium solani in a patient with aplastic anemia. New York State Journal of Medicine 1990, 90: 609–910.
Helm TN, Longworth DL, Hall GS, Bolwell BJ, Fernandez B, Tomecki KJ Case report and review of resolved fusariosis. Journal of the American Academy of Dermatology 1990, 23: 393–398.
Lupinetti FM, Giller RG, Trigg ME Operative treatment ofFusarium fungal infection of the lung. Annals of Thoracic Surgery 1990, 49: 991–992.
Nadler JP Disseminated fusarial infection. Reviews of Infectious Diseases 1990, 12: 162.
Schneller FRG, Gulati SC, Cunningham IB, O'Reilly RJ, Schmitt HJ, Clarkson BD Fusarium infections in patients with hematologic malignancies. Leukemia Research 1990, 14: 961–966.
Viscoli C, Castagnola E, Moroni C, Garaventa A, Manno G, Savioli C Infection withFusarium species in two children with neuroblastoma. European Journal of Clinical Microbiology & Infectious Diseases 1990, 9: 773–776.
Robertson MJ, Socinski MA, Soiffer RJ, Finberg RW, Wilson C, Anderson KC, Bosserman L, Sang DN, Salkin IF, Ritz J Successful treatment of disseminatedFusarium infection after autologous bone marrow transplantation for acute myeloid leukemia. Bone Marrow Transplantation 1991, 8: 143–145.
Viviani AM, Cofrancesco E, Boschetti C, Tortorano AM, Cortellaro M Eradication ofFusarium infection in a leukopenic patient treated with liposomal amphotericin B. Mycoses 1991, 34: 255–256.
Cofrancesco E, Boschetti C, Viviani MA, Bargiggia C, Tortorano AM, Cortellaro M, Zanussi C Efficacy of liposomal amphotericin B (AmBisome) in the eradication ofFusarium infection in a leukaemic patient. Haematologica 1992, 77: 280–283.
Girmenia C, Arcese W, Micozzi A, Martino P, Bianco P, Morace G Onychomycosis as a possible origin of dissaminatedFusarium solani infection in a patient with severe aplastic anemia. Clinical Infectious Diseases 1992, 14: 1167.
Neumeister B, Bartmann P, Gaedicke G, Marre R A fatal infection due toFusarium oxysporum in a child with Wilms' tumour. Case report and review of the literature. Mycoses 1992, 35: 115–119.
Anaissie EJ, Rinaldi MG Fusarium and the immunocompromised host: liaisons dangereuses. New York State Journal of Medicine 1990, 90: 586–587.
Galgiani G Antifungal susceptibility tests. Antimicrobial Agents and Chemotherapy 1987, 31: 1867–1870.
Lacroix C, Jacquemin JL Mycoses profondes dues àAcremonium et àFusarium. Bulletin de la Société Française de Mycologie Médicale 1988, XVII: 351–356.
Anaissie EJ, Hachem R, Legrand C, Legenne P, Nelson P, Bodey G Lack of activity of amphotericin B in systemic murine fusarial infection. Journal of Infectious Diseases 1992, 165: 1155–1157.
Rotowa NA, Shadomy HJ, Shadomy S In vitro activities of polyene and imidazole antifungal agents against unusual opportunistic fungal pathogens. Mycoses 1990, 33: 203–211.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rabodonirina, M., Piens, M.A., Monier, M.F. et al. Fusarium infections in immunocompromised patients: Case reports and literature review. Eur. J. Clin. Microbiol. Infect. Dis. 13, 152–161 (1994). https://doi.org/10.1007/BF01982190
Issue Date:
DOI: https://doi.org/10.1007/BF01982190